Chimeric antigen receptor (CAR)-T cell therapy has shown promise but remains limited against solid tumors. This study reports that DKK1-A2 CAR-T cells selectively target HLA-A2- and DKK1-positive tumors, suggesting their therapeutic potential in treating human cancers.
- Yufei Zhang
- Wei Xiong
- Qing Yi